The following article suggests benefits in testing a patient's tumor in an immunodeficient mice to predict drug response:
http://www.ncbi.nlm.nih.gov/pubmed/24705963
Here about the company that does it:
http://championsoncology.com/healthcare-professionals/tumorgraft-process/